Drug - Renova
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Tretinoin
Multiple ingredients are in alphabetical order.

Strength - 0.05%
The potency of the active ingredient(s), Tretinoin. May repeat for multiple part products.

The firm name holding legal responsibility for Renova. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019963
The FDA assigned number to Renova. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Renova. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB2
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 29, 1995
The date Renova was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Renova. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Renova is in. Format is RX, OTC, DISCN.

Applicant Full Name - Johnson And Johnson Consumer Companies Inc
The full name of the firm holding legal responsibility for the new application of Renova.